634
Views
32
CrossRef citations to date
0
Altmetric
Articles

Sequential antibiotic and growth factor releasing chitosan-PAAm semi-IPN hydrogel as a novel wound dressing

, , &
Pages 807-819 | Received 11 Jun 2012, Accepted 31 Jul 2012, Published online: 29 Aug 2012
 

Abstract

The aim of this study is to prepare a novel wound dressing material which provides burst release of an antibiotic in combination with sustained release of growth factor delivery. This might be beneficial for the prevention of infections and to stimulate wound healing. As a wound dressing material, the semi-interpenetrating network (semi-IPN) hydrogel based on polyacrylamide (PAAm) and chitosan (CS) was synthesized via free radical polymerization. Ethylene glycol dimethacrylate was used for cross-linking of PAAm to form semi-IPN hydrogel. The hydrogel shows high water content (∼1800%, in dry basis) and stable swelling characteristics in the pH range of the wound media (∼4.0–7.4). The antibiotic, piperacillin–tazobactam, which belongs to the penicillin group was loaded into the hydrogel. The therapeutic serum dose of piperacillin–tazobactam for topic introduction was reached at 1st hour of the release. Additionally, in order to increase the mitogenic activity of hydrogel, epidermal growth factor (EGF) was embedded into the CS–PAAm in different amounts. Cell culture studies were performed with L929 mouse fibroblasts and the simulated cell growth was investigated by 3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide assay. The successful sustained release behavior of CS–PAAm hydrogel for EGF maintained the presence of EGF in the culture up to 5 days and the highest mitochondrial activities were recorded for the 0.4 μg EGF-loaded/mg of hydrogel group. In conclusion, CS–PAAm semi-IPN hydrogel loaded with piperacillin–tazobactam and EGF could be proposed for an effective system in wound-healing management.

Acknowledgement

The financial and technical support of the research from Gazi University Research Fund (FEF 05/2006-39) is gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.